Patients with Multiple Myeloma Develop SOX2-Specific Autoantibodies after Allogeneic Stem Cell Transplantation

Patients with Multiple Myeloma Develop SOX2-Specific Autoantibodies after Allogeneic Stem Cell Transplantation

The occurrence of SOX2-specific autoantibodies seems to be associated with an improved prognosis in patients with monoclonal gammopathy of undetermined significance (MGUS). However, it is unclear if SOX2-specific antibodies also develop in established multiple myeloma (MM). Screening 1094 peripheral...

Full description

Saved in:
Bibliographic Details
Main Authors: Sebastian Kobold, Sinje Tams, Tim Luetkens, Yanran Cao, Orhan Sezer, Britta Marlen Bartels, Henrike Reinhard, Julia Templin, Katrin Bartels, York Hildebrandt, Nesrine Lajmi, Andreas Marx, Friedrich Haag, Carsten Bokemeyer, Nicolaus Kröger, Djordje Atanackovic
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2011/302145
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://dx.doi.org/10.1155/2011/302145

Similar Items